Paradoxical deterioration during treatment of tuberculous meningitis responded to infliximab but not to steroids
European Journal of Case Reports in Internal Medicine · 15.11.2024 · 11 (12)
DOI: 10.12890/2024_004822 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Case Reports in Internal Medicine, online erschienen am 15.11.2024. Verfasst von Almir Husic und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University Center of Internal Medicine, Cantonal Hospital Baselland, Liestal, Switzerland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Paradoxical deterioration in patients with tuberculous meningitis is a significant diagnostic and treatment challenge. We present the case of a 55-year-old previously healthy male, human immunodeficiency virus (HIV)-negative, presenting with headache, fever, agitation and slurred speech, who was ultimately diagnosed with tuberculous meningoencephalitis confirmed by cerebrospinal fluid polymerase chain reaction positive for Mycobacterium tuberculosis complex. After initiation of a standard antitubercular therapy combined with glucocorticoids, the patient experienced an initial neurological improvement. However, after 3 months of therapy, he had a major stroke with neurological deterioration, clinically and radiologically attributable to a paradoxical deterioration or an immune reconstruction syndrome as described in HIV-positive patients. Due to the persistence of inflammatory symptoms and radiological evidence of worsening tuberculomas despite ongoing antituberculosis therapy, off-label use of the tumour necrosis factor (TNF) inhibitor infliximab was initiated. The patient received three doses of infliximab at 5 mg/kg at monthly intervals, which led to marked clinical and radiological improvement. Follow-up magnetic resonance imaging showed regression of lesions, and the patient was eventually discharged with a significant recovery of motor and speech functions. This case underscores the potential of TNF inhibitors in managing severe cases of paradoxical deterioration in patients with tuberculous meningitis, challenging existing treatment paradigms and suggesting a need for further research into the pathophysiology and treatment of this condition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University Center of Internal Medicine, Cantonal Hospital Baselland, Liestal, Switzerland.
- Department of Internal Medicine, Cantonal Hospital Graubünden, Chur, Switzerland.
- Institute of Radiology and Nuclear Medicine, Cantonal Hospital Baselland, Liestal, Switzerland.
- Department of Infectious Diseases, University Center of Internal Medicine, Cantonal Hospital Baselland, Liestal, Switzerland.
Zitieren
APA
Husic, A., Jäggi, J., Müller, B., Dashti, D., Wirz, S., Potlukova, E., & Angelini, A. (2024). Paradoxical deterioration during treatment of tuberculous meningitis responded to infliximab but not to steroids. European Journal of Case Reports in Internal Medicine, 11(12). https://doi.org/10.12890/2024_004822
Vancouver
Husic A, Jäggi J, Müller B, Dashti D, Wirz S, Potlukova E, et al. Paradoxical deterioration during treatment of tuberculous meningitis responded to infliximab but not to steroids. European Journal of Case Reports in Internal Medicine. 2024;11(12). doi:10.12890/2024_004822
BibTeX
@article{Husic2024,
author = {Husic, Almir and Jäggi, Jonas and Müller, Benjamin and Dashti, David and Wirz, Sebastian and Potlukova, Eliska and Angelini, Alessandra},
title = {Paradoxical deterioration during treatment of tuberculous meningitis responded to infliximab but not to steroids},
journal = {European Journal of Case Reports in Internal Medicine},
year = {2024},
volume = {11},
number = {12},
doi = {10.12890/2024_004822}
}
EUVIMED